Tower Research Capital (TRC)’s Travere Therapeutics TVTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $370K | Buy |
|
|||||
|
2025
Q1 | $63.2K | Sell |
|
|||||
|
2024
Q4 | $372K | Buy |
|
|||||
|
2024
Q3 | $96.1K | Sell |
|
|||||
|
2024
Q2 | $114K | Buy |
|
|||||
|
2024
Q1 | $8.48K | Sell |
|
|||||
|
2023
Q4 | $54.2K | Sell |
|
|||||
|
2023
Q3 | $70.9K | Buy |
|
|||||
|
2023
Q2 | $93K | Buy |
|
|||||
|
2023
Q1 | $71K | Sell |
|
|||||
|
2022
Q4 | $112K | Sell |
|
|||||
|
2022
Q3 | $199K | Sell |
|
|||||
|
2022
Q2 | $481K | Buy |
|
|||||
|
2022
Q1 | $275K | Buy |
|
|||||
|
2021
Q4 | $226K | Buy |
|
|||||
|
2021
Q3 | $133K | Buy |
|
|||||
|
2021
Q2 | $72K | Buy |
|
|||||
|
2021
Q1 | $59K | Buy |
|
|||||
|
2020
Q4 | $42K | Sell |
|
|||||
|
2020
Q3 | $39K | Sell |
|
|||||
|
2020
Q2 | $105K | Buy |
|
|||||
|
2019
Q4 | – | Sell |
|
|||||
|
2019
Q3 | $16K | Buy |
|
|||||
|
2019
Q2 | $26K | Buy |
|
|||||
|
2018
Q1 | – | Sell |
|
|||||
|
2017
Q4 | $29K | Sell |
|
|||||
|
2017
Q3 | $167K | Buy |
|
|||||
|
2017
Q2 | $6K | Buy |
|
|||||
|
2017
Q1 | – | Sell |
|
|||||
|
2016
Q4 | $27K | Buy |
|
|||||
|
2016
Q3 | $21K | Buy |
|
|||||
|
2016
Q1 | – | Sell |
|
|||||
|
2015
Q4 | $10K | Sell |
|
|||||
|
2015
Q3 | $24K | Sell |
|
|||||
|
2015
Q2 | $58K | Sell |
|
|||||
|
2015
Q1 | $133K | Buy |
|
|||||
|
2014
Q4 | $28K | Sell |
|
|||||
|
2014
Q3 | $52K | Buy |
|
|||||
|
2014
Q2 | – | Sell |
|
|||||
|
2014
Q1 | $110K | Buy |
|